Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Multiparametric Analysis of Circulating Exosomes and Other Small Extracellular Vesicles by Advanced Imaging Flow Cytometry.

Mastoridis S, Bertolino GM, Whitehouse G, Dazzi F, Sanchez-Fueyo A, Martinez-Llordella M.

Front Immunol. 2018 Jul 6;9:1583. doi: 10.3389/fimmu.2018.01583. eCollection 2018.

2.

Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation.

Trento C, Bernardo ME, Nagler A, Kuçi S, Bornhäuser M, Köhl U, Strunk D, Galleu A, Sanchez-Guijo F, Gaipa G, Introna M, Bukauskas A, Le Blanc K, Apperley J, Roelofs H, Van Campenhout A, Beguin Y, Kuball J, Lazzari L, Avanzini MA, Fibbe W, Chabannon C, Bonini C, Dazzi F.

Biol Blood Marrow Transplant. 2018 Jul 20. pii: S1083-8791(18)30402-6. doi: 10.1016/j.bbmt.2018.07.015. [Epub ahead of print]

3.

Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice.

Pievani A, Michelozzi IM, Rambaldi B, Granata V, Corsi A, Dazzi F, Biondi A, Serafini M.

Sci Rep. 2018 Jun 14;8(1):9125. doi: 10.1038/s41598-018-27425-x.

4.

Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP.

Greco R, Ciceri F, Noviello M, Bondanza A, Vago L, Oliveira G, Peccatori J, Cieri N, Ruggeri A, Koehl U, Fleischhauer K, Rocha V, Dazzi F, van der Werf SM, Eikema DJ, Terwel SR, Kuball J, Toubert A, Chabannon C, Bonini C; EBMT Cellular Therapy and Immunobiology Working Party (CTIWP).

Bone Marrow Transplant. 2018 Sep;53(9):1201-1205. doi: 10.1038/s41409-018-0167-8. Epub 2018 Apr 17. No abstract available.

PMID:
29666449
5.

Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies.

Chabannon C, Kuball J, Bondanza A, Dazzi F, Pedrazzoli P, Toubert A, Ruggeri A, Fleischhauer K, Bonini C.

Sci Transl Med. 2018 Apr 11;10(436). pii: eaap9630. doi: 10.1126/scitranslmed.aap9630. Review.

PMID:
29643233
6.

Mesenchymal-myeloid interaction in the regulation of immunity.

Cheung TS, Dazzi F.

Semin Immunol. 2018 Feb;35:59-68. doi: 10.1016/j.smim.2018.01.002. Epub 2018 Feb 1. Review.

PMID:
29395680
7.

Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of Cancer.

Muliaditan T, Opzoomer JW, Caron J, Okesola M, Kosti P, Lall S, Van Hemelrijck M, Dazzi F, Tutt A, Grigoriadis A, Gillett CE, Madden SF, Burchell JM, Kordasti S, Diebold SS, Spicer JF, Arnold JN.

Clin Cancer Res. 2018 Apr 1;24(7):1617-1628. doi: 10.1158/1078-0432.CCR-17-2587. Epub 2018 Jan 16.

PMID:
29339440
8.

Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies.

Scarfe L, Brillant N, Kumar JD, Ali N, Alrumayh A, Amali M, Barbellion S, Jones V, Niemeijer M, Potdevin S, Roussignol G, Vaganov A, Barbaric I, Barrow M, Burton NC, Connell J, Dazzi F, Edsbagge J, French NS, Holder J, Hutchinson C, Jones DR, Kalber T, Lovatt C, Lythgoe MF, Patel S, Patrick PS, Piner J, Reinhardt J, Ricci E, Sidaway J, Stacey GN, Starkey Lewis PJ, Sullivan G, Taylor A, Wilm B, Poptani H, Murray P, Goldring CEP, Park BK.

NPJ Regen Med. 2017 Oct 19;2:28. doi: 10.1038/s41536-017-0029-9. eCollection 2017. Review.

9.

Roadmap to clinical translation: insights from a UK regenerative medicine platform workshop on mesenchymal stromal cells.

Asante CO, Dazzi F.

Regen Med. 2017 Dec 15. doi: 10.2217/rme-2017-0097. [Epub ahead of print] No abstract available.

10.

Effects of maternal obesity on Wharton's Jelly mesenchymal stromal cells.

Badraiq H, Cvoro A, Galleu A, Simon M, Miere C, Hobbs C, Schulz R, Siow R, Dazzi F, Ilic D.

Sci Rep. 2017 Dec 14;7(1):17595. doi: 10.1038/s41598-017-18034-1.

11.

Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.

Galleu A, Riffo-Vasquez Y, Trento C, Lomas C, Dolcetti L, Cheung TS, von Bonin M, Barbieri L, Halai K, Ward S, Weng L, Chakraverty R, Lombardi G, Watt FM, Orchard K, Marks DI, Apperley J, Bornhauser M, Walczak H, Bennett C, Dazzi F.

Sci Transl Med. 2017 Nov 15;9(416). pii: eaam7828. doi: 10.1126/scitranslmed.aam7828.

12.

Advances in mesenchymal stromal cell therapy in the management of Crohn's disease.

Ibraheim H, Giacomini C, Kassam Z, Dazzi F, Powell N.

Expert Rev Gastroenterol Hepatol. 2018 Feb;12(2):141-153. doi: 10.1080/17474124.2018.1393332. Epub 2017 Nov 2. Review.

PMID:
29096549
13.

Factor structure of the Brief Psychiatric Rating Scale - Expanded (BPRS-E) in a large hospitalized sample.

Shafer A, Dazzi F, Ventura J.

J Psychiatr Res. 2017 Oct;93:79-86. doi: 10.1016/j.jpsychires.2017.05.011. Epub 2017 May 28.

PMID:
28605626
14.

Psychopathological Assessment of Risk of Restraint in Acute Psychiatric Patients.

Dazzi F, Tarsitani L, Di Nunzio M, Trincia V, Scifoni G, Ducci G.

J Nerv Ment Dis. 2017 Jun;205(6):458-465. doi: 10.1097/NMD.0000000000000672.

PMID:
28319591
15.

Monomeric, porous type II collagen scaffolds promote chondrogenic differentiation of human bone marrow mesenchymal stem cells in vitro.

Tamaddon M, Burrows M, Ferreira SA, Dazzi F, Apperley JF, Bradshaw A, Brand DD, Czernuszka J, Gentleman E.

Sci Rep. 2017 Mar 3;7:43519. doi: 10.1038/srep43519.

16.

Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery.

Trento C, Marigo I, Pievani A, Galleu A, Dolcetti L, Wang CY, Serafini M, Bronte V, Dazzi F.

Haematologica. 2017 May;102(5):818-825. doi: 10.3324/haematol.2016.155390. Epub 2017 Feb 9.

17.

Complement C3 Exacerbates Imiquimod-Induced Skin Inflammation and Psoriasiform Dermatitis.

Giacomassi C, Buang N, Ling GS, Crawford G, Cook HT, Scott D, Dazzi F, Strid J, Botto M.

J Invest Dermatol. 2017 Mar;137(3):760-763. doi: 10.1016/j.jid.2016.11.011. Epub 2016 Nov 19. No abstract available.

18.

Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo.

Michelozzi IM, Pievani A, Pagni F, Antolini L, Verna M, Corti P, Rovelli A, Riminucci M, Dazzi F, Biondi A, Serafini M.

Br J Haematol. 2017 Nov;179(4):669-673. doi: 10.1111/bjh.14234. Epub 2016 Aug 2. No abstract available.

PMID:
27480905
19.

Meta-analysis of the Brief Psychiatric Rating Scale - Expanded (BPRS-E) structure and arguments for a new version.

Dazzi F, Shafer A, Lauriola M.

J Psychiatr Res. 2016 Oct;81:140-51. doi: 10.1016/j.jpsychires.2016.07.001. Epub 2016 Jul 4. Review.

PMID:
27451107
20.

Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector.

Sweeney NP, Regan C, Liu J, Galleu A, Dazzi F, Lindemann D, Rupar CA, McClure MO.

Mol Ther. 2016 Aug;24(7):1227-36. doi: 10.1038/mt.2016.91. Epub 2016 May 2.

21.

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG, Planat V, Shi Y, Stroncek DF, Viswanathan S, Weiss DJ, Sensebe L.

Cytotherapy. 2016 Feb;18(2):151-9. doi: 10.1016/j.jcyt.2015.11.008. Epub 2015 Dec 23.

22.

Predictors of inpatient psychiatric admission in patients presenting to the emergency department: the role of dimensional assessment.

Dazzi F, Picardi A, Orso L, Biondi M.

Gen Hosp Psychiatry. 2015 Nov-Dec;37(6):587-94. doi: 10.1016/j.genhosppsych.2015.08.005. Epub 2015 Aug 21.

PMID:
26380874
23.

Classification and biology of tumour associated stromal cells.

Raffaghello L, Dazzi F.

Immunol Lett. 2015 Dec;168(2):175-82. doi: 10.1016/j.imlet.2015.06.016. Epub 2015 Jul 2. Review.

PMID:
26145459
24.

The UKRMP Immunomodulation hub.

Dazzi F, Conroy E.

Regen Med. 2015;10(3):255-7. doi: 10.2217/rme.15.5. No abstract available. Erratum in: Regen Med. 2015;10(5):680.

25.

Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis.

Mattoscio M, Nicholas R, Sormani MP, Malik O, Lee JS, Waldman AD, Dazzi F, Muraro PA.

Neurology. 2015 Apr 7;84(14):1473-82. doi: 10.1212/WNL.0000000000001454. Epub 2015 Mar 11.

26.

Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.

Devito L, Badraiq H, Galleu A, Taheem DK, Codognotto S, Siow R, Khalaf Y, Briley A, Shennan A, Poston L, McGrath J, Gentleman E, Dazzi F, Ilic D.

Regen Med. 2014;9(6):723-32. doi: 10.2217/rme.14.60.

PMID:
25431909
27.

[Neurotransmitters: gender's differences].

Dazzi F, Scicchitano C.

Riv Psichiatr. 2014 Sep-Oct;49(5):237-4. doi: 10.1708/1668.18264. Review. Italian.

PMID:
25424337
28.

Black hole physics. Black hole lightning due to particle acceleration at subhorizon scales.

Aleksić J, Ansoldi S, Antonelli LA, Antoranz P, Babic A, Bangale P, Barrio JA, Becerra González J, Bednarek W, Bernardini E, Biasuzzi B, Biland A, Blanch O, Bonnefoy S, Bonnoli G, Borracci F, Bretz T, Carmona E, Carosi A, Colin P, Colombo E, Contreras JL, Cortina J, Covino S, Da Vela P, Dazzi F, De Angelis A, De Caneva G, De Lotto B, de Oña Wilhelmi E, Delgado Mendez C, Dominis Prester D, Dorner D, Doro M, Einecke S, Eisenacher D, Elsaesser D, Fonseca MV, Font L, Frantzen K, Fruck C, Galindo D, García López RJ, Garczarczyk M, Garrido Terrats D, Gaug M, Godinović N, González Muñoz A, Gozzini SR, Hadasch D, Hanabata Y, Hayashida M, Herrera J, Hildebrand D, Hose J, Hrupec D, Idec W, Kadenius V, Kellermann H, Kodani K, Konno Y, Krause J, Kubo H, Kushida J, La Barbera A, Lelas D, Lewandowska N, Lindfors E, Lombardi S, Longo F, López M, López-Coto R, López-Oramas A, Lorenz E, Lozano I, Makariev M, Mallot K, Maneva G, Mankuzhiyil N, Mannheim K, Maraschi L, Marcote B, Mariotti M, Martínez M, Mazin D, Menzel U, Miranda JM, Mirzoyan R, Moralejo A, Munar-Adrover P, Nakajima D, Niedzwiecki A, Nilsson K, Nishijima K, Noda K, Orito R, Overkemping A, Paiano S, Palatiello M, Paneque D, Paoletti R, Paredes JM, Paredes-Fortuny X, Persic M, Poutanen J, Prada Moroni PG, Prandini E, Puljak I, Reinthal R, Rhode W, Ribó M, Rico J, Rodriguez Garcia J, Rügamer S, Saito T, Saito K, Satalecka K, Scalzotto V, Scapin V, Schultz C, Schweizer T, Shore SN, Sillanpää A, Sitarek J, Snidaric I, Sobczynska D, Spanier F, Stamatescu V, Stamerra A, Steinbring T, Storz J, Strzys M, Takalo L, Takami H, Tavecchio F, Temnikov P, Terzić T, Tescaro D, Teshima M, Thaele J, Tibolla O, Torres DF, Toyama T, Treves A, Uellenbeck M, Vogler P, Zanin R, Kadler M, Schulz R, Ros E, Bach U, Krauß F, Wilms J.

Science. 2014 Nov 28;346(6213):1080-4. doi: 10.1126/science.1256183. Epub 2014 Nov 6.

29.

Unique regulatory properties of mesangial cells are genetically determined in the rat.

Lai PC, Chiu LY, Srivastava P, Trento C, Dazzi F, Petretto E, Cook HT, Behmoaras J.

PLoS One. 2014 Oct 24;9(10):e111452. doi: 10.1371/journal.pone.0111452. eCollection 2014.

30.

Offering mental health services in a conflict affected region of Pakistan: who comes, and why?

Shah S, Van den Bergh R, Van Bellinghen B, Severy N, Sadiq S, Afridi SA, Akhtar A, Maïkére J, Van Overloop C, Saeed-ur-Rehman, Khilji TB, Saleem-ur-Rehman, van Griensven J, Schneider S, Bosman P, Guillergan EL, Dazzi F, Zachariah R.

PLoS One. 2014 Jun 25;9(6):e97939. doi: 10.1371/journal.pone.0097939. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e103700.

31.

Are the imaging findings used to assess the portal triad reliable to perform living-donor liver transplant?

Dazzi FL, Ribeiro MA Jr, Mancero JM, Gonzalez AM, Leão-Filho HM, de Oliveira e Silva A, D'Albuquerque LA.

Arq Bras Cir Dig. 2013 Nov-Dec;26(4):296-301. English, Portuguese.

32.

The diagnostic classification of eating disorders: current situation, possible alternatives and future perspectives.

Dazzi F, Di Leone FG.

Eat Weight Disord. 2014 Mar;19(1):11-9. doi: 10.1007/s40519-013-0076-1. Epub 2013 Oct 9. Review.

PMID:
24104389
33.

Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells.

Auner HW, Moody AM, Ward TH, Kraus M, Milan E, May P, Chaidos A, Driessen C, Cenci S, Dazzi F, Rahemtulla A, Apperley JF, Karadimitris A, Dillon N.

PLoS One. 2013 Sep 17;8(9):e74415. doi: 10.1371/journal.pone.0074415. eCollection 2013.

34.

Cancer makes new friends with old tricks.

Dazzi F.

Blood. 2013 Aug 15;122(7):1093-4. doi: 10.1182/blood-2013-06-509620.

35.

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.

Ruutu T, Gratwohl A, de Witte T, Afanasyev B, Apperley J, Bacigalupo A, Dazzi F, Dreger P, Duarte R, Finke J, Garderet L, Greinix H, Holler E, Kröger N, Lawitschka A, Mohty M, Nagler A, Passweg J, Ringdén O, Socié G, Sierra J, Sureda A, Wiktor-Jedrzejczak W, Madrigal A, Niederwieser D.

Bone Marrow Transplant. 2014 Feb;49(2):168-73. doi: 10.1038/bmt.2013.107. Epub 2013 Jul 29. Erratum in: Bone Marrow Transplant. 2014 Feb;49(2):319. Dosage error in article text.

PMID:
23892326
36.

Enhanced and aberrant T cell trafficking following total body irradiation: a gateway to graft-versus-host disease?

Vianello F, Cannella L, Coe D, Chai JG, Golshayan D, Marelli-Berg FM, Dazzi F.

Br J Haematol. 2013 Sep;162(6):808-18. doi: 10.1111/bjh.12472. Epub 2013 Jul 15.

PMID:
23855835
37.

MSCs: science and trials.

Fibbe WE, Dazzi F, LeBlanc K.

Nat Med. 2013 Jul;19(7):812-3. doi: 10.1038/nm.3222. No abstract available.

PMID:
23836217
38.

Alterations of the olfactory-gustatory functions in patients with eating disorders.

Dazzi F, Nitto SD, Zambetti G, Loriedo C, Ciofalo A.

Eur Eat Disord Rev. 2013 Sep;21(5):382-5. doi: 10.1002/erv.2238. Epub 2013 Jun 20.

PMID:
23788398
39.

Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment.

Mussai F, De Santo C, Abu-Dayyeh I, Booth S, Quek L, McEwen-Smith RM, Qureshi A, Dazzi F, Vyas P, Cerundolo V.

Blood. 2013 Aug 1;122(5):749-58. doi: 10.1182/blood-2013-01-480129. Epub 2013 Jun 3.

40.

Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT.

Innes AJ, Beattie R, Sergeant R, Damaj G, Foroni L, Marin D, Kanfer E, Mielke S, Milojkovic D, MacDonald D, Pavlu J, Rahemtulla A, Roberts I, Slade D, Bray E, Goldman J, Apperley J, Szydlo R, Dazzi F, Rezvani K.

Bone Marrow Transplant. 2013 Oct;48(10):1324-8. doi: 10.1038/bmt.2013.69. Epub 2013 May 20.

PMID:
23686098
41.

Clinical perspectives of mesenchymal stem cells.

Kramer J, Dazzi F, Dominici M, Schlenke P, Wagner W.

Stem Cells Int. 2012;2012:684827. doi: 10.1155/2012/684827. Epub 2012 Dec 24. No abstract available.

42.

Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation.

Basak GW, de Wreede LC, van Biezen A, Wiktor-Jedrzejczak W, Halaburda K, Schmid C, Schaap N, Dazzi F, von dem Borne PA, Petersen E, Beelen D, Abayomi A, Volin L, Buzyn A, Gurman G, Bunjes D, Guglielmi C, Olavarria E, de Witte T.

Bone Marrow Transplant. 2013 Jun;48(6):837-42. doi: 10.1038/bmt.2012.234. Epub 2012 Nov 26.

PMID:
23178548
43.

Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance?

Burr SP, Dazzi F, Garden OA.

Immunol Cell Biol. 2013 Jan;91(1):12-8. doi: 10.1038/icb.2012.60. Epub 2012 Nov 13. Review.

PMID:
23146942
44.

Mesenchymal stromal cells: a key player in 'innate tolerance'?

Dazzi F, Lopes L, Weng L.

Immunology. 2012 Nov;137(3):206-13. doi: 10.1111/j.1365-2567.2012.03621.x. Review.

45.

Regulatory T cells in stem cell transplantation: main characters or walk-on actors?

Fozza C, Dazzi F.

Crit Rev Oncol Hematol. 2012 Oct;84(1):18-25. doi: 10.1016/j.critrevonc.2012.02.003. Epub 2012 Mar 3. Review.

PMID:
22386896
46.

Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

Chaidos A, Patterson S, Szydlo R, Chaudhry MS, Dazzi F, Kanfer E, McDonald D, Marin D, Milojkovic D, Pavlu J, Davis J, Rahemtulla A, Rezvani K, Goldman J, Roberts I, Apperley J, Karadimitris A.

Blood. 2012 May 24;119(21):5030-6. doi: 10.1182/blood-2011-11-389304. Epub 2012 Feb 27.

47.

Regulatory T cell therapy for the induction of clinical organ transplantation tolerance.

Fan H, Cao P, Game DS, Dazzi F, Liu Z, Jiang S.

Semin Immunol. 2011 Dec;23(6):453-61. doi: 10.1016/j.smim.2011.08.012. Epub 2011 Sep 14. Review.

PMID:
21920772
48.

EBMT risk score predicts outcome of allogeneic hematopoietic stem cell transplantation in patients who have failed a previous transplantation procedure.

Rezvani K, Kanfer EJ, Marin D, Gabriel I, Rahemtulla A, Taylor A, Macdonald D, Dazzi F, Milojkovic D, Foroni L, Pavlu J, Sargent J, Le Dieu R, Goldman JM, Apperley J, Szydlo R.

Biol Blood Marrow Transplant. 2012 Feb;18(2):235-40. doi: 10.1016/j.bbmt.2011.06.010. Epub 2011 Jun 30.

49.

The immunomodulatory properties of mesenchymal stem cells.

Marigo I, Dazzi F.

Semin Immunopathol. 2011 Nov;33(6):593-602. doi: 10.1007/s00281-011-0267-7. Epub 2011 Apr 19. Review.

PMID:
21499984
50.

Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate.

Capelli C, Gotti E, Morigi M, Rota C, Weng L, Dazzi F, Spinelli O, Cazzaniga G, Trezzi R, Gianatti A, Rambaldi A, Golay J, Introna M.

Cytotherapy. 2011 Aug;13(7):786-801. doi: 10.3109/14653249.2011.563294. Epub 2011 Mar 18.

PMID:
21417678

Supplemental Content

Support Center